Literature DB >> 12404575

The platelet as a peripheral marker in psychiatric illness.

Helein Plein1, Michael Berk.   

Abstract

The identification of peripheral markers of psychiatric illness is important if an improvement in the diagnosis and treatment of various diseases with overlapping symptomatology is desired. There are many disorders that not only have overlapping symptomatology, but also have similar biological disturbances. The functional capability of the neurons involved in the disease processes may be at the crux of the underlying pathology. The platelet intracellular calcium response to neurotransmitter stimulation has previously been used as a peripheral marker of psychiatric illness. This review discusses evidence in support of the extended use of the platelet as a peripheral marker. The use of the platelet intracellular calcium response to neurotransmitter stimulation as a state or trait marker in major depression, the specificity and selectivity of this response, and the possible use of the platelet as a peripheral marker in psychotic disorders such as schizophrenia, mania and psychotic depression are shown. Finally, a proposed mechanism for the association between certain psychiatric disorders and cardiovascular disease is discussed. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Year:  2001        PMID: 12404575     DOI: 10.1002/hup.251

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  13 in total

1.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

Authors:  Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

2.  The Effect of Psychoactive Drugs on in vitro Platelet Function.

Authors:  Angelika Schedel; Sophia Thornton; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2010-08-25       Impact factor: 3.747

Review 3.  Serotonin transporters: implications for antidepressant drug development.

Authors:  Kellie J White; Crystal C Walline; Eric L Barker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 4.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

5.  Human depression: a new approach in quantitative psychiatry.

Authors:  Massimo Cocchi; Lucio Tonello; Mark M Rasenick
Journal:  Ann Gen Psychiatry       Date:  2010-06-03       Impact factor: 3.455

6.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

Review 7.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

8.  PLATELET SEROTONIN AS BIOMARKER FOR ASSESSING SUICIDAL BEHAVIOUR IN PATIENTS WITH BIPOLAR I DISORDER.

Authors:  A Giurgiuca; S Schipor; A Caragheorgheopol; A Crasan; E Postolache; C Tudose; D Prelipceanu; D Cozman
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

9.  How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.

Authors:  Steven Moylan; Felice N Jacka; Julie A Pasco; Michael Berk
Journal:  Brain Behav       Date:  2013-03-26       Impact factor: 2.708

Review 10.  Using lithium as a neuroprotective agent in patients with cancer.

Authors:  Mustafa Khasraw; David Ashley; Greg Wheeler; Michael Berk
Journal:  BMC Med       Date:  2012-11-02       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.